The report provides a detailed analysis of the current myelodysplastic syndrome marketed drugs and late-stage pipeline drugs.

Happy Soxx The memoir follows the author's experience with Myelodysplastic Syndrome and the life he continued to build beyond the diagnosis ...

Acquisition adds Phase 2 ready novel VISTA inhibiting monoclonal antibody (mAb) to TuHURA's late-stage immuno-oncology pipeline TuHURA planning to initiate a Phase ...

A panelist discusses a typical lower-risk myelodysplastic syndrome case managed with luspatercept over ...

The Little Rock community gathered for Rozanne Pumphrey, a mother and grandmother who is battling myelodysplastic syndrome.

A new blood test can detect leukemia and blood aging risks non-invasively, potentially replacing painful bone marrow biopsies ...

Saint Mark Baptist Church is hosting a drive to find one of their members a stem cell match during her fight against cancer.

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Innate immune signals and p53 contribute to the 5q– myelodysplastic syndrome, an acquired bone marrow failure disorder (pages 49–58 and 59–66 ).

By Denny Jacob AbbVie said its Phase 3 trial evaluating venetoclax in combination with azacitidine to treat higher-risk myelodysplastic syndrome didn't meet the primary endpoint of overall survival.

Key Highlights Topline read-out from the Phase II BEXMAB trial confirms earlier positive findings in both frontline and relapsed/refractory higher-risk myelodysplastic syndrome (HR MDS) patients ...

Myelodysplastic Syndrome (MDS) – causes, symptoms, and treatment: Myelodysplastic Syndrome (MDS) is a group of disorders in which the bone marrow produces abnormally shaped or abnormal blood cells.